Rs12778366 single nucleotide polymorphism of Sirtuin 1 (SIRT1) and response to resveratrol supplementation in patients with type 2 diabetes mellitus

Acta Diabetol. 2019 Aug;56(8):963-966. doi: 10.1007/s00592-019-01341-6. Epub 2019 Apr 12.

Authors

Roberto Gambino¹, Giovanni Fanni¹, Gabriele Togliatto¹, Valentina Ponzo¹, Ilaria Goitre¹, Maurizio Cassader¹, Maria Felice Brizzi², Simona Bo³

Affiliations

¹ Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy.
² Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy. [email protected].
³ Department of Medical Sciences, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy. [email protected].

PMID: 30980188
DOI: 10.1007/s00592-019-01341-6

No abstract available

Publication types

Observational Study

MeSH terms

Aged
Case-Control Studies
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / genetics
Diabetes Mellitus, Type 2 / metabolism
Dietary Supplements / analysis
Female
Humans
Male
Middle Aged
Polymorphism, Single Nucleotide*
Resveratrol / administration & dosage*
Sirtuin 1 / genetics*
Sirtuin 1 / metabolism

Substances

SIRT1 protein, human
Sirtuin 1
Resveratrol

Grants and funding